In silico molecular target prediction unveils mebendazole as a potent MAPK14 inhibitor.
Ariey-Bonnet J, Carrasco K, Le Grand M, Hoffer L, Betzi S, Feracci M, Tsvetkov P, Devred F, Collette Y, Morelli X, Ballester P, Pasquier E
Publications
Targeting Functional Activity of AKT Has Efficacy against Aggressive Neuroblastoma.
Le Grand M, Kimpton K, Gana CC, Valli E, Fletcher JI, Kavallaris M
Stathmin levels alter PTPN14 expression and impact neuroblastoma cell migration.
Po'uha ST, Le Grand M, Brandl MB, Gifford AJ, Goodall GJ, Khew-Goodall Y, Kavallaris M